| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |